Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion type Assertion NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_head.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion wasGeneratedBy ECO_0000203 NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion wasDerivedFrom befree-2016 NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion SIO_000772 23627936 NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion evidence source_evidence_literature NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.